Published in Tissue Eng Part B Rev on August 22, 2016
The price of innovation: new estimates of drug development costs. J Health Econ (2003) 23.43
Reengineering translational science: the time is right. Sci Transl Med (2011) 7.55
Translational research: crossing the valley of death. Nature (2008) 5.02
Scaffold translation: barriers between concept and clinic. Tissue Eng Part B Rev (2011) 1.25
A systematic review of animal models used to study nerve regeneration in tissue-engineered scaffolds. Biomaterials (2012) 1.18
Managing Clinical Knowledge for Health Care Improvement. Yearb Med Inform (2000) 1.02
Barriers to the clinical translation of orthopedic tissue engineering. Tissue Eng Part B Rev (2011) 0.98
Barriers and strategies for the clinical translation of advanced orthopaedic tissue engineering protocols. Eur Cell Mater (2014) 0.90
The Challenge for Reconstructive Surgeons in the Twenty-First Century: Manufacturing Tissue-Engineered Solutions. Front Surg (2015) 0.83
Safe Delivery of Anti-Fibrotic Reagents into the Intra-Articular Rabbit Knee Using Biodegradable Oligo [Poly(ethylene glycol) Fumarate] (OPF) Implants. Tissue Eng Part C Methods (2016) 0.75